Teachers Advisors’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Teachers Advisors’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-910	Closed	-$20K	–	3268
2014 Q1	$20K	Hold	910	–	–	﹤0.01%	3098
2013 Q4	$32K	Hold	910	–	–	﹤0.01%	3081
2013 Q3	$33K	Sell	910 -9	-1%	-$410	﹤0.01%	3053
2013 Q2	$42K	Buy	+919	New	+$41.7K	﹤0.01%	3029

Other funds holding KBIO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Teachers Advisors's KBIO Position: Q2 2014 in Review

Teachers Advisors sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q2 2014, closing a stake of 910 shares — an estimated $20K sold.

Teachers Advisors first reported a position in KBIO in Q2 2013 and held it in 4 quarters. The position peaked at $42K in Q2 2013. 43 funds tracked by Wall St. Rank hold KBIO as of Q2 2014.

Teachers Advisors reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q2 2014 after selling out during the quarter.
Teachers Advisors sold 910 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q2 2014, an estimated $20K.
Teachers Advisors first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 4 quarters.
Teachers Advisors's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $42K in Q2 2013.
43 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q2 2014.

Based on Teachers Advisors's 13F filing for Q2 2014, filed 13 Aug 2014.